International Clinical Trial: Single-Center Prospective Study of Homoharringtonine Combined with Azacitidine and Venetoclax in the Treatment of Adult Patients with Newly Diagnosed Acute Myeloid Leukemia

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120015) titled 'Single-Center Prospective Study of Homoharringtonine Combined with Azacitidine and Venetoclax in the Treatment of Adult Patients with Newly Diagnosed Acute Myeloid Leukemia' on March 8.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Hospital of China Medical University

Condition: Acute Myeloid Leukemia

Intervention: HHT+AZA+VEN Treatment Group:HHT: 1.0 mg/m^2 IV on days 1-7 Venetoclax: 200 mg on day 1, 400 mg on day 2, 100 mg IV on days 3-14

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-08

Target Sample Size: HHT+AZA+VEN Treatm...